North America Oncolytic Virus Therapy Market by Manufacturers, Countries, Type and Application, Forecast to 2023

May 2018 | 108 pages | ID: NCC20122CD3EN
GlobalInfoResearch

Abstracts

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Scope of the Report:

This report focuses on the Oncolytic Virus Therapy in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers

• Amgen
• Oncolytics Biotech
• Viralytics
• Transgene SA
• Oncolys BioPharma
• Targovax
• PsiOxus Therapeutics
• SillaJen Biotherapeutics
• Sorrento Therapeutics
• Lokon Pharma
• Genelux Corporation
• Vyriad
• TILT Biotherapeutics
• Cold Genesys

Market Segment by Countries, coveringMarket Segment by Type, covers

• Melanoma
• Prostate Cancer
• Breast Cancer
• Ovarian Cancer
• Others

Market Segment by Applications, can be divided into

• Melanoma
• Prostate Cancer
• Breast Cancer
• Ovarian Cancer
• Others

There are 15 Chapters to deeply display the North America Oncolytic Virus Therapy market.

Chapter 1, to describe Oncolytic Virus Therapy Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Oncolytic Virus Therapy, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Oncolytic Virus Therapy, for each country, from 2013 to 2018;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Oncolytic Virus Therapy market forecast, by countries, type and application, with sales, price and revenue, from 2018 to 2023;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Oncolytic Virus Therapy Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Oncolytic Virus Therapy Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
  1.3.1 Melanoma
  1.3.2 Prostate Cancer
  1.3.3 Breast Cancer
  1.3.4 Ovarian Cancer
  1.3.5 Others
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2013-2023)
  1.4.2 Mexico Status and Prospect (2013-2023)
  1.4.3 Canada Status and Prospect (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Amgen
  2.1.1 Business Overview
  2.1.2 Oncolytic Virus Therapy Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Amgen Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Oncolytics Biotech
  2.2.1 Business Overview
  2.2.2 Oncolytic Virus Therapy Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Oncolytics Biotech Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Viralytics
  2.3.1 Business Overview
  2.3.2 Oncolytic Virus Therapy Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Viralytics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Transgene SA
  2.4.1 Business Overview
  2.4.2 Oncolytic Virus Therapy Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Transgene SA Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Oncolys BioPharma
  2.5.1 Business Overview
  2.5.2 Oncolytic Virus Therapy Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Oncolys BioPharma Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Targovax
  2.6.1 Business Overview
  2.6.2 Oncolytic Virus Therapy Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Targovax Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 PsiOxus Therapeutics
  2.7.1 Business Overview
  2.7.2 Oncolytic Virus Therapy Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 SillaJen Biotherapeutics
  2.8.1 Business Overview
  2.8.2 Oncolytic Virus Therapy Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sorrento Therapeutics
  2.9.1 Business Overview
  2.9.2 Oncolytic Virus Therapy Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Lokon Pharma
  2.10.1 Business Overview
  2.10.2 Oncolytic Virus Therapy Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 Lokon Pharma Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Genelux Corporation
  2.11.1 Business Overview
  2.11.2 Oncolytic Virus Therapy Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 Genelux Corporation Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Vyriad
  2.12.1 Business Overview
  2.12.2 Oncolytic Virus Therapy Type and Applications
    2.12.2.1 Type
    2.12.2.2 Type
  2.12.3 Vyriad Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 TILT Biotherapeutics
  2.13.1 Business Overview
  2.13.2 Oncolytic Virus Therapy Type and Applications
    2.13.2.1 Type
    2.13.2.2 Type
  2.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Cold Genesys
  2.14.1 Business Overview
  2.14.2 Oncolytic Virus Therapy Type and Applications
    2.14.2.1 Type
    2.14.2.2 Type
  2.14.3 Cold Genesys Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 NORTH AMERICA ONCOLYTIC VIRUS THERAPY MARKET COMPETITION, BY MANUFACTURER

3.1 North America Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
  3.1.1 North America Oncolytic Virus Therapy Sales by Manufacturer (2016-2017)
  3.1.2 North America Oncolytic Virus Therapy Sales Market Share by Manufacturer (2016-2017)
3.2 North America Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
  3.2.1 North America Oncolytic Virus Therapy Revenue by Manufacturer (2016-2017)
  3.2.2 North America Oncolytic Virus Therapy Revenue Market Share by Manufacturer (2016-2017)
3.3 North America Oncolytic Virus Therapy Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Oncolytic Virus Therapy Manufacturer Market Share (2016-2017)
  3.4.2 Top 5 Oncolytic Virus Therapy Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend

4 NORTH AMERICA ONCOLYTIC VIRUS THERAPY MARKET ANALYSIS BY COUNTRIES

4.1 North America Oncolytic Virus Therapy Sales and Market Share by Countries (2013-2018)
  4.1.1 North America Oncolytic Virus Therapy Sales by Countries (2013-2018)
  4.1.2 North America Oncolytic Virus Therapy Sales Market Share by Countries (2013-2018)
4.2 North America Oncolytic Virus Therapy Revenue (Value) and Market Share by Countries (2013-2018)
  4.2.1 North America Oncolytic Virus Therapy Revenue by Countries (2013-2018)
  4.2.2 North America Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)

5 NORTH AMERICA MARKET SEGMENTATION ONCOLYTIC VIRUS THERAPY BY TYPE

5.1 North America Oncolytic Virus Therapy Sales, Revenue and Market Share by Type (2013-2018)
  5.1.1 North America Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
  5.1.2 North America Oncolytic Virus Therapy Revenue and Market Share by Type (2013-2018)
5.2 Type 1 Sales Growth Rate and Price

6 NORTH AMERICA MARKET SEGMENTATION ONCOLYTIC VIRUS THERAPY BY APPLICATION

6.1 North America Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
6.2 Melanoma Sales Growth (2013-2018)
6.3 Prostate Cancer Sales Growth (2013-2018)
6.4 Breast Cancer Sales Growth (2013-2018)
6.5 Ovarian Cancer Sales Growth (2013-2018)
6.6 Others Sales Growth (2013-2018)

7 UNITED STATES ONCOLYTIC VIRUS THERAPY SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Oncolytic Virus Therapy Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Oncolytic Virus Therapy Sales and Market Share by Type
  7.2.1 United States Oncolytic Virus Therapy Sales by Type (2013-2018)
  7.2.2 United States Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
7.3 United States Oncolytic Virus Therapy Sales and Market Share by Application (2013-2018)
  7.3.1 United States Oncolytic Virus Therapy Sales by Application (2013-2018)
  7.3.2 United States Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
7.4 United States Oncolytic Virus Therapy Sales, Revenue and Market Share by Manufacturer (2016-2017)
  7.4.1 United States Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
  7.4.2 United States Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Oncolytic Virus Therapy Export and Import (2013-2018)

8 CANADA ONCOLYTIC VIRUS THERAPY SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Oncolytic Virus Therapy Revenue, Sales and Growth Rate (2013-2018)
8.2 Canada Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
  8.2.1 Canada Oncolytic Virus Therapy Sales by Type (2013-2018)
  8.2.2 Canada Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
8.3 Canada Oncolytic Virus Therapy Sales and Market Share by Application (2013-2018)
  8.3.1 Canada Oncolytic Virus Therapy Sales by Application (2013-2018)
  8.3.2 Canada Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
8.4 Canada Oncolytic Virus Therapy Sales, Revenue and Market Share by Manufacturer (2016-2017)
  8.4.1 Canada Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
  8.4.2 Canada Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
8.5 Canada Oncolytic Virus Therapy Export and Import (2013-2018)

9 MEXICO ONCOLYTIC VIRUS THERAPY SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Oncolytic Virus Therapy Revenue, Sales and Growth Rate (2013-2018)
9.2 Mexico Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
  9.2.1 Mexico Oncolytic Virus Therapy Sales by Type (2013-2018)
  9.2.2 Mexico Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
9.3 Mexico Oncolytic Virus Therapy Sales and Market Share by Application (2013-2018)
  9.3.1 Mexico Oncolytic Virus Therapy Sales by Application (2013-2018)
  9.3.2 Mexico Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
9.4 Mexico Oncolytic Virus Therapy Sales, Revenue and Market Share by Manufacturer (2016-2017)
  9.4.1 Mexico Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
  9.4.2 Mexico Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
9.5 Mexico Oncolytic Virus Therapy Export and Import (2013-2018)

10 ONCOLYTIC VIRUS THERAPY MARKET FORECAST (2018-2023)

10.1 North America Oncolytic Virus Therapy Sales, Revenue and Growth Rate (2018-2023)
10.2 Oncolytic Virus Therapy Market Forecast by Countries (2018-2023)
  10.2.1 North America Oncolytic Virus Therapy Sales Forecast by Countries (2018-2023)
  10.2.2 United States Oncolytic Virus Therapy Forecast (2018-2023)
  10.2.3 Canada Oncolytic Virus Therapy Forecast (2018-2023)
  10.2.4 Mexico Oncolytic Virus Therapy Forecast (2018-2023)
10.3 Oncolytic Virus Therapy Market Forecast by Type (2018-2023)
  10.3.1 North America Oncolytic Virus Therapy Sales Forecast by Type (2018-2023)
  10.3.2 North America Oncolytic Virus Therapy Market Share Forecast by Type (2018-2023)
10.4 Oncolytic Virus Therapy Market Forecast by Application (2018-2023)
  10.4.1 North America Oncolytic Virus Therapy Sales Forecast by Application (2018-2023)
  10.4.2 North America Oncolytic Virus Therapy Market Share Forecast by Application (2018-2023)

11 ONCOLYTIC VIRUS THERAPY MANUFACTURING COST ANALYSIS

11.1 Oncolytic Virus Therapy Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Oncolytic Virus Therapy

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Oncolytic Virus Therapy Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Oncolytic Virus Therapy Major Manufacturers in 2017
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Oncolytic Virus Therapy Picture
Table Product Specifications of Oncolytic Virus Therapy
Figure North America Sales Market Share of Oncolytic Virus Therapy by Types in 2017
Table Types of Oncolytic Virus Therapy
Figure North America Oncolytic Virus Therapy Sales Market Share by Applications in 2017
Table Applications of Oncolytic Virus Therapy
Figure Melanoma Picture
Figure Prostate Cancer Picture
Figure Breast Cancer Picture
Figure Ovarian Cancer Picture
Figure Others Picture
Figure United States Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Mexico Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Canada Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Oncolytic Virus Therapy Type and Applications
Table Amgen Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Oncolytics Biotech Basic Information, Manufacturing Base and Competitors
Table Oncolytics Biotech Oncolytic Virus Therapy Type and Applications
Table Oncolytics Biotech Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Viralytics Basic Information, Manufacturing Base and Competitors
Table Viralytics Oncolytic Virus Therapy Type and Applications
Table Viralytics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Transgene SA Basic Information, Manufacturing Base and Competitors
Table Transgene SA Oncolytic Virus Therapy Type and Applications
Table Transgene SA Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Oncolys BioPharma Basic Information, Manufacturing Base and Competitors
Table Oncolys BioPharma Oncolytic Virus Therapy Type and Applications
Table Oncolys BioPharma Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Targovax Basic Information, Manufacturing Base and Competitors
Table Targovax Oncolytic Virus Therapy Type and Applications
Table Targovax Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table PsiOxus Therapeutics Basic Information, Manufacturing Base and Competitors
Table PsiOxus Therapeutics Oncolytic Virus Therapy Type and Applications
Table PsiOxus Therapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SillaJen Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Type and Applications
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sorrento Therapeutics Oncolytic Virus Therapy Type and Applications
Table Sorrento Therapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lokon Pharma Basic Information, Manufacturing Base and Competitors
Table Lokon Pharma Oncolytic Virus Therapy Type and Applications
Table Lokon Pharma Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genelux Corporation Basic Information, Manufacturing Base and Competitors
Table Genelux Corporation Oncolytic Virus Therapy Type and Applications
Table Genelux Corporation Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vyriad Basic Information, Manufacturing Base and Competitors
Table Vyriad Oncolytic Virus Therapy Type and Applications
Table Vyriad Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table TILT Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table TILT Biotherapeutics Oncolytic Virus Therapy Type and Applications
Table TILT Biotherapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cold Genesys Basic Information, Manufacturing Base and Competitors
Table Cold Genesys Oncolytic Virus Therapy Type and Applications
Table Cold Genesys Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Oncolytic Virus Therapy Sales by Manufacturer (2016-2017)
Table North America Oncolytic Virus Therapy Sales Market Share by Manufacturer (2016-2017)
Figure North America Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2016
Figure North America Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2017
Table North America Oncolytic Virus Therapy Revenue by Manufacturer (2016-2017)
Table North America Oncolytic Virus Therapy Revenue Market Share by Manufacturer (2016-2017)
Figure North America Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2016
Figure North America Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2017
Table North America Oncolytic Virus Therapy Price by Manufacturers (2016-2017)
Figure Top 3 Oncolytic Virus Therapy Manufacturer Market Share in 2016
Figure Top 3 Oncolytic Virus Therapy Manufacturer Market Share in 2017
Figure Top 5 Oncolytic Virus Therapy Manufacturer Market Share in 2016
Figure Top 5 Oncolytic Virus Therapy Manufacturer Market Share in 2017
Table North America Oncolytic Virus Therapy Sales by Countries (2013-2018)
Figure North America Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Table North America Oncolytic Virus Therapy Sales Market Share by Countries (2013-2018)
Figure North America 2013 Oncolytic Virus Therapy Sales Market Share by Countries
Figure North America 2017 Oncolytic Virus Therapy Sales Market Share by Countries
Table North America Oncolytic Virus Therapy Revenue by Countries (2013-2018)
Figure North America Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table North America Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
Figure North America 2013 Oncolytic Virus Therapy Revenue Market Share by Countries
Figure North America 2017 Oncolytic Virus Therapy Revenue Market Share by Countries
Table North America Oncolytic Virus Therapy Sales by Type (2013-2018)
Table North America Oncolytic Virus Therapy Sales Share by Type (2013-2018)
Table North America Oncolytic Virus Therapy Revenue by Type (2013-2018)
Table North America Oncolytic Virus Therapy Revenue Share by Type (2013-2018)
Table North America Oncolytic Virus Therapy Sales by Application (2013-2018)
Table North America Oncolytic Virus Therapy Sales Share by Application (2013-2018)
Figure North America Melanoma Sales Growth (2013-2018)
Figure North America Prostate Cancer Sales Growth (2013-2018)
Figure North America Breast Cancer Sales Growth (2013-2018)
Figure North America Ovarian Cancer Sales Growth (2013-2018)
Figure North America Others Sales Growth (2013-2018)
Figure United States Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure United States Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Table United States Oncolytic Virus Therapy Sales by Type (2013-2018)
Table United States Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
Table United States Oncolytic Virus Therapy Sales by Application (2013-2018)
Table United States Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
Table United States Oncolytic Virus Therapy Sales by Manufacturer (2016-2017)
Figure United States Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2016
Figure United States Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2017
Table United States Oncolytic Virus Therapy Revenue by Manufacturer (2016-2017)
Figure United States Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2016
Figure United States Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2017
Table United States Oncolytic Virus Therapy Export and Import (2013-2018)
Figure Canada Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Canada Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Table Canada Oncolytic Virus Therapy Sales by Type (2013-2018)
Table Canada Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
Table Canada Oncolytic Virus Therapy Sales by Application (2013-2018)
Table Canada Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
Table Canada Oncolytic Virus Therapy Sales by Manufacturer (2016-2017)
Figure Canada Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2016
Figure Canada Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2017
Table Canada Oncolytic Virus Therapy Revenue by Manufacturer (2016-2017)
Figure Canada Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2016
Figure Canada Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2017
Table Canada Oncolytic Virus Therapy Export and Import (2013-2018)
Figure Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Mexico Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Table Mexico Oncolytic Virus Therapy Sales by Type (2013-2018)
Table Mexico Oncolytic Virus Therapy Sales Market Share by Type (2013-2018)
Table Mexico Oncolytic Virus Therapy Sales by Application (2013-2018)
Table Mexico Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
Table Mexico Oncolytic Virus Therapy Sales by Manufacturer (2016-2017)
Figure Mexico Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2016
Figure Mexico Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2017
Table Mexico Oncolytic Virus Therapy Revenue by Manufacturer (2016-2017)
Figure Mexico Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2016
Figure Mexico Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2017
Table Mexico Oncolytic Virus Therapy Export and Import (2013-2018)
Figure North America Oncolytic Virus Therapy Sales, Revenue and Growth Rate (2018-2023)
Table North America Oncolytic Virus Therapy Sales Forecast by Countries (2018-2023)
Table North America Oncolytic Virus Therapy Market Share Forecast by Countries (2018-2023)
Figure United States Oncolytic Virus Therapy Sales Forecast (2018-2023)
Figure Canada Oncolytic Virus Therapy Sales Forecast (2018-2023)
Figure Mexico Oncolytic Virus Therapy Sales Forecast (2018-2023)
Table North America Oncolytic Virus Therapy Sales Forecast by Type (2018-2023)
Table North America Oncolytic Virus Therapy Market Share Forecast by Type (2018-2023)
Table North America Oncolytic Virus Therapy Sales Forecast by Application (2018-2023)
Table North America Oncolytic Virus Therapy Market Share Forecast by Application (2018-2023)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncolytic Virus Therapy
Figure Manufacturing Process Analysis of Oncolytic Virus Therapy
Figure Oncolytic Virus Therapy Industrial Chain Analysis
Table Raw Materials Sources of Oncolytic Virus Therapy Major Manufacturers in 2017
Table Major Buyers of Oncolytic Virus Therapy
Table Distributors/Traders/ Dealers List